Yahoo Web Search

Sign In

Search results

  1. altamiratherapeutics.comAltamira Therapeutics: Targeting unmet medical needs

    Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore™ / SemaPhore™ delivery platforms). The Company currently has two flagship siRNA programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis.

    • About

      Thomas Meyer founded Auris Medical (renamed Altamira...

    • RNA Programs

      Altamira’s OligoPhore™ / SemaPhore™ platform is a versatile...

    • Legacy Programs

      The legacy programs of Altamira comprise Bentrio ®, an...

    • Investors & Media

      Investors & Media. Overview. Altamira Therapeutics is...

    • SEC Filings

      ex-101.sch - xbrl taxonomy extension schema. effect: other

    • Press Releases

      Investors & Media. Press Releases. Year. Altamira...

  2. ir.altamiratherapeutics.comInvestor Relations - Altamira Therapeutics

    May 28, 2024 · Investors & Media. Overview. Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets (OligoPhore™ / SemaPhore™ delivery platforms).

  3. altamiratherapeutics.com › investors-media › newsroomNewsroom - Altamira Therapeutics

    Peptide-Based Nonoparticles for Extrahepatic Delivery of Therapeutic #RNA. Chimica Oggi/Chemistry Today, 2023, vol.41 (6) LINK. Targeting Cancer with RNA Therapeutics.

  4. www.altamiracorp.comHome - Altamira

    Altamira advances critical National Security missions with tech-enabled multi-intelligence solutions and critical operations that are informed by mission experts, accelerated by data scientists and delivered by elite technical talent.

    • Altamira Media1
    • Altamira Media2
    • Altamira Media3
    • Altamira Media4
    • Altamira Media5

  5. ir.altamiratherapeutics.com › news-releases › news-releaseAltamira Therapeutics Provides Investor and Business Update |...

    Dec 11, 2023 · Investors & Media. Release Details. Altamira Therapeutics Provides Investor and Business Update. December 11, 2023. PDF Version. HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ET.

  6. ir.altamiratherapeutics.com › news-releases › news-releaseAltamira Therapeutics Provides Business Update

    May 28, 2024 · Investors & Media. Release Details. Altamira Therapeutics Provides Business Update. May 28, 2024. PDF Version. Hamilton, Bermuda, May 28, 2024 (GLOBE NEWSWIRE) -- Achieved significant improvement in handling and transport stability of RNA nanoparticles.

  7. en.wikipedia.org › wiki › Cave_of_AltamiraCave of Altamira - Wikipedia

    The Cave of Altamira ( / ˌæltəˈmɪərə / AL-tə-MEER-ə; Spanish: Cueva de Altamira [ˈkweβa ðe altaˈmiɾa]) is a cave complex, located near the historic town of Santillana del Mar in Cantabria, Spain. It is renowned for prehistoric cave art featuring charcoal drawings and polychrome paintings of contemporary local fauna and human hands.